nach oben

Journal of Neurology

Erschienen in:

09.07.2020 | Letter to the Editors

Neuromyelitis optica and myotonic dystrophy type 2: a rare association with diagnostic implications

verfasst von: Stefano Gelibter, Lucia Moiola, Stefano Carlo Previtali, Massimo Filippi

Erschienen in: Journal of Neurology | Ausgabe 9/2020

Einloggen, um Zugang zu erhalten

Excerpt

Dear Sirs, …

Bradl M, Kanamori Y, Nakashima I, Misu T, Fujihara K, Lassmann H et al (2014) Pain in neuromyelitis optica—prevalence, pathogenesis and therapy. Nat Rev Neurol 10(9):529–536. https://doi.org/10.1038/nrneurol.2014.129CrossRefPubMed

Seok JM, Choi M, Cho EB, Lee HL, Kim BJ, Lee KH et al (2017) Fatigue in patients with neuromyelitis optica spectrum disorder and its impact on quality of life (Paul F, editor). PLoS ONE 12(5):e0177230. https://doi.org/10.1371/journal.pone.0177230CrossRefPubMedPubMedCentral

He D, Zhang A, Li Y, Cai G, Li Y, Guo S (2017) Autoimmune aquaporin-4 induced damage beyond the central nervous system. Mult Scler Relat Disord 18:41–46. https://doi.org/10.1016/j.msard.2017.09.013CrossRefPubMed

Tieleman AA, den Broeder AA, van de Logt A-E, van Engelen BGM (2009) Strong association between myotonic dystrophy type 2 and autoimmune diseases. J Neurol Neurosurg Psychiatry 80(11):1293–1295. https://doi.org/10.1136/jnnp.2008.156562CrossRefPubMed

Karatzikou M, Bakirtzis C, Nikolaidis J, Parisis D, Grigoriadis N (2018) White matter hyperintensities in myotonic dystrophy type 2: not always another expression of the disease. Mult Scler Relat Disord 24:117–119. https://doi.org/10.1016/j.msard.2018.06.020CrossRefPubMed

Rakocevic-Stojanovic V, Peric S, Dujmovic I, Drulovic J, Pesovic J, Savic-Pavicevic D (2017) Neuromyelitis optica in a patient from family with both myotonic dystrophy type 1 and 2. J Neuromuscul Dis 4(1):89–92. https://doi.org/10.3233/JND-160192CrossRefPubMed

Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66(10):1485–1489. https://doi.org/10.1212/01.wnl.0000216139.44259.74CrossRefPubMed

Nikolic A, Stojanovic VR, Romac S, Savic D, Basta I, Lavrnic D (2013) The coexistence of myasthenia gravis and myotonic dystrophy type 2 in a single patient. J Clin Neurol 9(2):130. https://doi.org/10.3988/jcn.2013.9.2.130CrossRefPubMedPubMedCentral

Lien CF, Mohanta SK, Frontczak-Baniewicz M, Swinny JD, Zablocka B, Górecki DC (2012) Absence of glial α-dystrobrevin causes abnormalities of the blood–brain barrier and progressive brain edema. J Biol Chem 287(49):41374–41385. https://doi.org/10.1074/jbc.M112.400044CrossRefPubMedPubMedCentral

10.

Adams ME, Tesch Y, Percival JM, Albrecht DE, Conhaim JI, Anderson K et al (2008) Differential targeting of nNOS and AQP4 to dystrophin-deficient sarcolemma by membrane-directed -dystrobrevin. J Cell Sci 121(1):48–54. https://doi.org/10.1242/jcs.020701CrossRefPubMed

11.

Nakamori M, Kimura T, Kubota T, Matsumura T, Sumi H, Fujimura H et al (2008) Aberrantly spliced-dystrobrevin alters -syntrophin binding in myotonic dystrophy type 1. Neurology 70(9):677–685. https://doi.org/10.1212/01.wnl.0000302174.08951.cfCrossRefPubMed

12.

Gelibter S, Mazzi B, Tassara M, Colombo B, Guerrieri S, Giordano A et al (2018) Neuromyelitis optica spectrum disorder and multiple sclerosis in a Sardinian family. Mult Scler Relat Disord 25:73–76. https://doi.org/10.1016/j.msard.2018.07.017CrossRefPubMed

13.

Pandit L, Asgari N, Apiwattanakul M, Palace J, Paul F, Leite M et al (2015) Demographic and clinical features of neuromyelitis optica: a review. Mult Scler J 21(7):845–853. https://doi.org/10.1177/1352458515572406CrossRef

14.

Siciliano G, Manca M, Gennarelli M, Angelini C, Rocchi A, Iudice A et al (2002) Epidemiology of myotonic dystrophy in Italy: re-apprisal after genetic diagnosis: genetic epidemiology in DM. Clin Genet 59(5):344–349. https://doi.org/10.1034/j.1399-0004.2001.590508.xCrossRef

15.

Zhang W, Dong M, Dong H, Wang W, Sun W, Hao Y et al (2020) Reduced sarcolemmal aquaporin 4 expression can support the differential diagnosis of neuromyelitis optica spectrum disorders. J Neuroimmunol 339:577121. https://doi.org/10.1016/j.jneuroim.2019.577121CrossRefPubMed

Titel: Neuromyelitis optica and myotonic dystrophy type 2: a rare association with diagnostic implications
verfasst von: Stefano Gelibter
Lucia Moiola
Stefano Carlo Previtali
Massimo Filippi
Publikationsdatum: 09.07.2020
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Neurology / Ausgabe 9/2020
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-020-10049-5

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

25.04.2024 | Hypotonie | Nachrichten

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

23.04.2024 | Demenz | Nachrichten

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 | Parkinson-Krankheit | Podcast | Nachrichten

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Professorin Dr. Claudia Trenkwalder, Neurologin

22.04.2024 | DGIM 2024 | Nachrichten

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

weitere anzeigen

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2020

Exome sequencing in 38 patients with intracranial aneurysms and subarachnoid hemorrhage

Emerging treatments for neuromyelitis optica spectrum disorder

Ioflupane 123I (DAT scan) SPECT identifies dopamine receptor dysfunction early in the disease course in progressive apraxia of speech

SPG7 mutations in amyotrophic lateral sclerosis: a genetic link to hereditary spastic paraplegia

The contribution of enhancing lesions in monitoring multiple sclerosis treatment: is gadolinium always necessary?

Non-epileptic seizures in autonomic dysfunction as the initial symptom of COVID-19